The inclusion criteria for this clinical trial are crucial for ensuring the right candidates participate, leading to accurate and effective results. Infants diagnosed with pulmonary hypertension from birth are considered. It’s essential for participants to meet specific health conditions to be eligible, including stable cardiac function and absence of other severe congenital anomalies. The trial is also age-restricted, focusing on newborns to assess the direct impact of Vardenafil and Sildenafil during the earliest stages of life.
The study is designed to compare the efficacy and safety of Vardenafil and Sildenafil in treating pulmonary hypertension in newborns. Conducted in a controlled environment, the trial involves close monitoring of participants to evaluate the drugs’ effects on reducing pulmonary artery pressure and improving oxygenation. By employing a randomized, double-blind methodology, the study aims to eliminate bias and produce reliable data on each drug’s performance.
In Riyadh, the Children’s Hospital plays a pivotal role in conducting this study. As a renowned facility for pediatric care, it offers state-of-the-art resources and a dedicated team of specialists focused on neonatal health. Their commitment ensures that participating infants receive the best possible care throughout the trial.
If this particular study doesn’t fit your needs, consider visiting Arabvirilityhealth dot com for alternative solutions. The site provides information on various treatments for different health conditions, helping you find a path that aligns with your health goals. Arabvirilityhealth dot com offers valuable resources and options for those seeking additional assistance beyond this specific clinical trial.